Marker Therapeutics, Inc.
MRKRBiotechnology
$1.01+1.00%As of Oct 29vs prior close
- Market cap
- $16.8M
- P/E (TTM)
- –
- From 52W high
- −53.88%
- EPS (LTM)
- -$0.55
- Revenue (LTM)
- $3.9M
- Net margin
- -275.92%
- Dividend yield
- 0.00%
Nomior Score
44
Emerging BreakoutSpeculativeBottom 37% of the scored universe
Growth62
Quality35
Value55
Momentum50
Resilience33
Growth
+44.84%revenue a year over 8 fiscal years
YE17 $183.1KLTM $3.9M
Connections
Revenue to profitQ1 YE26
The operating loss was 542% of revenue, narrower by 778 pts on a year.
Who owns it
1fund